Abbott Recalls 13 Million Pregnancy Tests Globally
The worldwide recall affects professional-use tests that may produce false-positive results due to high sensitivity.
Updated on Oct. 15, 2026 in Pregnancy
Live Poll
Do you trust the reliability of medical supplies currently used in your local healthcare facilities?
Abbott initiated a global recall of over 13 million pregnancy tests on August 20, 2026, after discovering the devices may yield false-positive results. The affected units are intended for use by healthcare professionals rather than home consumers.
Why it matters
The tests may incorrectly detect low levels of human chorionic gonadotropin (hCG), potentially leading to inaccurate diagnostic outcomes for patients in clinical settings. The recall aims to prevent diagnostic errors by updating instructions for medical staff.
The recall involves more than 13 million units, including approximately 2,800 units distributed to healthcare facilities in Canada. The affected diagnostic tests are manufactured for professional clinical use.
The players
Abbott
Abbott is a global medical device and health care company that manufactures a wide range of diagnostic tests and nutritional products.
FDA
The FDA is a federal agency within the U.S. Department of Health and Human Services responsible for protecting public health through the regulation of medical products.
The details
The recall covers multiple models sold through suppliers like Fisher Scientific, McKesson, and Cardinal Health. While these tests are now subject to updated usage instructions, the manufacturer has advised that the products do not need to be physically returned.
Timeline
August 20, 2026: Abbott initiated the global field action for the pregnancy tests.
September 25, 2026: The FDA posted the official recall notice to its website.
October 2026: Gizmodo confirmed the distribution of the affected tests within the United States.
Culture Shift
This recall aligns with the FDA's Medical Device Reporting regulations which dictate the transparency and safety standards required for large-scale medical product withdrawals. By issuing updated guidance instead of a full physical return, the company follows a growing industry trend toward surgical interventions in product safety management.
Because these tests are restricted to healthcare professionals, patients do not need to take action regarding home testing kits. If you have concerns about a recent clinical pregnancy test result, consult your healthcare provider for clinical confirmation.
The takeaway
Patients who receive unexpected results from clinical pregnancy tests should request follow-up blood work or ultrasound confirmation. Healthcare providers should review the updated Abbott instructions to ensure accurate interpretation of hCG levels.
Further reading
For additional insights on prenatal care and clinical testing, visit the Pregnancy section.
Source note: This article includes information reported by Gizmodo.
Live Poll
Do you trust the reliability of medical supplies currently used in your local healthcare facilities?
